Our research group is committed to tackling a diverse array of biomedical challenges, focusing on critical areas such as diabetes, cancer, and neurodegenerative diseases like Alzheimer's. Grounded in the principles of medicinal biochemistry, we aim to develop innovative strategies that enhance the delivery and administration of therapeutic compounds for clinical use.
By integrating computational (in silico) and laboratory-based (in vitro and in vivo) methodologies, we explore complex biomedical issues with a comprehensive approach. Our primary objective is to improve drug efficacy and optimize therapeutic outcomes through advanced drug delivery systems, particularly in the realm of nanomedicine.
Through our dedicated efforts, we strive to make significant contributions to the field, ultimately enhancing the potency and effectiveness of existing treatments while addressing any limitations they may have.